Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TriSalus Life Sciences (TLSIW) Revenue (2022 - 2025)

Historic Revenue for TriSalus Life Sciences (TLSIW) over the last 4 years, with Q3 2025 value amounting to $11.6 million.

  • TriSalus Life Sciences' Revenue rose 5738.2% to $11.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.2 million, marking a year-over-year increase of 4951.84%. This contributed to the annual value of $29.4 million for FY2024, which is 5899.2% up from last year.
  • According to the latest figures from Q3 2025, TriSalus Life Sciences' Revenue is $11.6 million, which was up 5738.2% from $11.2 million recorded in Q2 2025.
  • TriSalus Life Sciences' Revenue's 5-year high stood at $11.6 million during Q3 2025, with a 5-year trough of $3.0 million in Q1 2023.
  • For the 4-year period, TriSalus Life Sciences' Revenue averaged around $6.7 million, with its median value being $6.5 million (2024).
  • Its Revenue has fluctuated over the past 5 years, first soared by 3237.32% in 2023, then skyrocketed by 11638.74% in 2024.
  • Over the past 4 years, TriSalus Life Sciences' Revenue (Quarter) stood at $3.2 million in 2022, then surged by 77.34% to $5.7 million in 2023, then soared by 44.4% to $8.3 million in 2024, then skyrocketed by 40.01% to $11.6 million in 2025.
  • Its Revenue was $11.6 million in Q3 2025, compared to $11.2 million in Q2 2025 and $9.2 million in Q1 2025.